Clinical efficacy of a novel oral SERD TFX06 in prior fulvestrant-treated ER+/HER2− advanced breast cancer patients in a dose expansion study.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Wenxing Qin, Jian Zhang, Yuping Sun, Yongsheng Wang, Hongqiang Guo, Yehui Shi, Zhiye Zhang, Tingjing Yao, Yiding Chen, Hao Zhang, Yunjiang Liu, Jia Song, Panpan Li, Wei Sha, Charles Z. Ding
Institutions: Fudan University Shanghai Cancer Center, Shandong Tumor Hospital, Shandong First Medical University, Henan Cancer Hospital, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Henan University of Science and Technology, First Affiliated Hospital of Henan University of Science and Technology, First Affiliated Hospital of Bengbu Medical College, Second Affiliated Hospital of Zhejiang University, Zhejiang University, Nanjing University of Science and Technology, Fourth Hospital of Hebei Medical University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162561760
Cites:
Cited by:
Related to:
